Analyst Ratings for Centessa Pharmaceuticals (CNTA)
CNTA Rating Summary
CNTA Price Target Summary
- Highest: $62.00 (Oppenheimer)
- Lowest: $35.00 (Wells Fargo)
- Average: $41.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$41.00 (+58%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 91%
Rating Score: 9.4 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
40.00 (N/A) |
24.50 (25.95) |
5.92% | Details |
| 12/10/2025 | Oppenheimer | Kostas Biliouris | New Coverage | Outperform (N/A) |
62.00 (N/A) |
28.60 (25.95) |
-9.27% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
